Abstract
Acute infectious diseases of the central nervous system, particularly bacterial meningitis and herpes simplex encephalitis (HSE), are neurological emergencies. These diseases often have no definitive symptoms or signs, which makes diagnosis difficult. Delayed diagnosis or treatment of bacterial meningitis or HSE leads to a poor prognosis.
If bacterial meningitis is clinically diagnosed, optimal antimicrobial therapy should be started within 1 h after initial contact with the patient. In Japan, pneumococcal and Haemophilus influenzae type b (Hib) meningitis account for 75% of all community-acquired bacterial meningitis cases, and most causative pathogens of these meningitis are resistant to ampicillin and third-generation cephem antibiotics. If pneumococcal meningitis is suspected, the choice of antibiotics should be strategically determined on the assumption that the etiologic agent is penicillin-resistant Streptococcus pneumoniae in Japan. Hib and pneumococcal vaccines contribute to reducing the frequency of bacterial meningitis.
The etiology of acute encephalitis is often unknown. HSE is one of the major causes, and its prognosis is extremely poor without treatment. Acyclovir (ACV) is the most efficient agent for the treatment of HSE. If acute encephalitis is clinically diagnosed, treatment with intravenous ACV (10 mg/kg, every 8 h for 14–21 days in immunocompetent patients) should be immediately started. In definitive HSE patients, ACV treatment should not be stopped until confirmation of HSV-negative polymerase chain reaction results in cerebral spinal fluid samples on two separate occasions. In patients with ACV-resistant HSE, adjunctive vidarabine or foscarnet should be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–59.
Kamei S, Takasu T. Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med. 2000;39:894–900.
Ubukata K, Chiba N, Hasegawa K, Kobayashi R, Iwata S, Sunakawa K. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother. 2004;48:1488–94.
Ishiwada N, Fukasawa C, Inami Y, Hishiki H, Takeda N, Sugita K, Kohno Y. Quantitative measurements of Hemophilus influenzae type b capsular polysaccharide antibodies in Japanese children. Pediatr Int. 2007;49:864–8.
Vyse A, Wolter JM, Chen J, Ng T, Soriano-Gabarro M. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect. 2011;139:967–85.
Shimojima Y, Ida M, Nakama A, Nishino Y, Fukui R, Kuroda S, Hirai A, Kai A, Sadamasu K. J Vet Med Sci. 2016;78:1183–7.
Practical Guideline for Bacterial Meningitis Development Committee. Practical guideline for bacterial meningitis 2014. Tokyo: Nankodo; 2014 [in Japanese].
Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314:144–9.
Practical Guideline for Herpes Simplex Encephalitis Development Committee. Practical guideline for herpes simplex encephalitis 2017. Tokyo: Nankodo; 2017 [in Japanese].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Morita, A., Ishihara, M. (2019). Acute Infections of the Central Nervous System: Focus on Bacterial Meningitis and Herpes Simplex Encephalitis. In: Kinoshita, K. (eds) Neurocritical Care . Springer, Singapore. https://doi.org/10.1007/978-981-13-7272-8_15
Download citation
DOI: https://doi.org/10.1007/978-981-13-7272-8_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7271-1
Online ISBN: 978-981-13-7272-8
eBook Packages: MedicineMedicine (R0)